Our Mission is Helping People to Transform Their Health

Americans have reached their breaking point,” said Shelley Lyford, president and CEO of West Health, a family of nonprofit, nonpartisan organizations dedicated to lowering healthcare costs to enable successful aging.

  • 38% say they put off treatment, up 12 percentage points from 2021
  • 27% say medical treatment was for a very or somewhat serious condition
  • Lower-income, younger adults, women most likely to report delaying care

Source: Gallup

"Thousands of competing products in the past nearly twenty-five years have failed in achieving what D'OXYVA® has obtained in terms of regulatory approvals, clinical safety and efficacy in the past seven years."
"Thousands of competing products in the past nearly twenty-five years have failed in achieving what D'OXYVA® has obtained in terms of regulatory approvals, clinical safety and efficacy in the past seven years." - Dr. Charles M. Zelen, CEO at Professional Education Research Institute (global clinical research organization)
Dr. Charles M. Zelen
CEO at Professional Education Research Institute (Global CRO)

We, at Circularity Healthcare believe in a long-sought-after goal in health care.

Access to a single health application that significantly improves mild-to-severe urgent unresolved health complications quickly, affordably, without pain, and without compromising other aspects of health.

Over 1 Million Applications in 36 Countries

Groundbreaking Pivotal Studies at 18 of the 20 Top-ranked U.S. Universities by World-renowned Medical Scientists & Doctors

D'OXYVA Dark Gray

Available at

Advanced Regenerative Solution

36 groundbreaking studies in 10 years | Exceptional safety & efficacy profile

0% adverse event reports | 97% of users report major results in 2-4 weeks

Experience the D'OXYVA® Advantage

"Health Uncensored with Dr. Drew" invites you to tell your D'OXYVA success story on Lifetime TV
Health-Uncensored-with-Dr-Drew-DOXYVA-Interview-Revolutionizing-Circulation-Breakthroughs-for-Enhancing-Blood-Flow-on-Lifetime-TV
Dr. Drew Pinsky
Health Uncensored with Dr. Drew

Published Clinical Study →

Placenta Accreta is a Serious Pregnancy Complication & D’OXYVA is Helping to Stop It

5-minute Applications, Hours of Benefits

✔ Elevate Cardiovascular, Microvascular, Neurological Health

✔ Alleviate Complex Conditions & Chronic Pain

✔ Achieve Top Athletic & Mental Performance & Healthy Weight

✔ Rapidly alleviate moderate-to-severe chronic pain in 2-4 weeks

✔ Significantly lower the risks of major cardiovascular events, alleviate underlying chronic complications especially for fibromyalgia, neuropathy, diabetes in 4-8 weeks

✔ Significantly fade the appearance of severe varicose veins in 4-8 weeks

✔ Significantly speed up chronic, burn, trauma wound healing in 2-4 weeks

✔ Boost stamina, athletic performance in 2-4 weeks, shed excess weight

D’OXYVA® is a pioneering, pain-free, non-invasive advanced regenerative transdermal technology with several granted patents in the U.S. and worldwide.

It’s clinically researched to work throughout the entire body via neurotransmitter molecules delivered over a thumb, or anywhere on the body.

Based on groundbreaking, randomized, double-blind, and placebo-controlled studies collected at world-renowned institutions such as Penn State University, it has shown to significantly improve lasting microvascular circulation (angiogenesis), oxygenated tissue perfusion and repair (Bohr effect), and autonomic nerve activities (parasympathetic), while reducing inflammation (homeostasis).

References →

Take D'OXYVA Based on the Severity of Conditions

Even Extremely Severe Cases with Multiple Complications Realized Life-changing Long-lasting Results in 4-8 Weeks with 1-4x Daily Applications

No prescription required. Get major immediate results with a pain-free application that is easy to use on the thumb, or anywhere on the body with zero adverse event reports.

Stop paying for expensive treatments, surgeries, and ointments. Instead, target your underlying conditions with our decade-long extensive medical research at an affordable cost.

With a lightweight applicator that’s perfect when you’re on the go, D’OXYVA® is self-administered with a gentle, water-based solution on the skin.

Don't Let Inferior Treatments Break Your Heart & the Bank

Our success underscores the significance in people’s daily lives of years of groundbreaking medical research regarding blood pressure, diabetes, and innovative approaches such as our over-the-skin spray solution for long-term chronic pain for improving overall well-being.

Over 97% of D’OXYVA® users in three dozen exceptionally positive studies, and thousands of happy customers in over two dozen countries reported major outcomes in just a few weeks. Learn more about us.

Get Instant Proof How Well It's Working for You

D'OXYVA advanced regenerative health tech

Experience hours of outsized nerve and circulation benefits with each application of this US-made groundbreaking solution, which includes the advanced long-term solution for fibromyalgia sufferers. Measure results with home diagnostic tools.

Family measuring D'Oxyva Perfusion Index (peripheral blood circulation), oxygen saturation, heart rate, respiratory rate results with special oximeter

Individuals seeking relief from conditions like fibromyalgia can explore our innovative approach, such as our fibromyalgia infusion solution and fibromyalgia biohacking science to significantly improve their well-being.

Get Instant Proof It's Working for You

Quick & Easy Way to Check Results

The finger pulse oximeter demonstrates the best D’OXYVA® results in 30-60 minutes.

Measure and record your critical peripheral blood flow (perfusion index), pulse rate, respiratory rate, and oxygen saturation via the finger.

Athletes, cardiac patients, and those who have circulatory pathologies will find the finger pulse oximeter to be an invaluable tool for monitoring their conditions, based on extensive cardiovascular medical research.

Regimen Recommended by Top Health Care Professionals

For best results, medical experts recommend starting with 1-3 daily D’OXYVA® applications for the first 3-5 weeks.

Then 1-2 daily or 2-3 weekly uses depending on the severity of underlying conditions and health goals.

This guidance is grounded in extensive medical research with D’OXYVA® on blood pressure, diabetes, microcirculation, tissue perfusion, and the autonomic nervous system, while it reflects on its superior safety and efficacy compared to cholesterol medications research results.

D'OXYVA: Revolutionizing Healthcare with Scientific Breakthroughs

Additional studies with D’OXYVA® are capitalizing on its exceptional results for high blood pressure medical research, research on blood pressure medications, medical research on chronic back and neck pain, and medical research on blood sugar.

The continuous dedication of medical students, rising stars, and world-renowned experts shapes the future of healthcare and our company is working with some of the foremost experts in each field, particularly in the fields of diabetes medical research, fibromyalgia, arthritis, and cardiovascular health.

D’OXYVA’s medical advisory team comprised of world-renowned experts has been providing groundbreaking evidence for various benefits with our advanced technology since 2012, including for fibromyalgia treatment, Epstein-Barr virus, osteoarthritis, and the benefits for lower cholesterol.

In this landscape of healthcare research, D’OXYVA® (deoxyhemoglobin vasodilator) emerges as a groundbreaking solution.

Backed by extensive medical research, D’OXYVA may significantly improve microcirculation, tissue perfusion, and autonomic nervous system functions for virtually all people.

D’OXYVA® is thought to effectively target underlying conditions, offering hope to individuals facing various health challenges, including severe neuropathy, chronic pain, arthritis, intimate complications, chronic wounds, varicose veins, peripheral vascular and cardiovascular complications.

D’OXYVA® is a promising option, especially when nothing else has worked.

Get Your Free Consultation